CYTOO S.A., announces today new results that demonstrate the ability of the Company’s 2D+ Cell Culture Platform to enable two new high content analysis approaches: quantitative density mapping of trafficking compartments and standardized mitochondrial analysis. The results will be presented next week at MiPTec 2012 in Basel by the researchers from the Institut Curie in Paris and Angers University Hospital/INSERM, France.